WALLINGFORD — Biomedical company CyVek has received a $445,683 grant from Connecticut Innovations Inc. (CII) to continue development of a blood testing platform.

CyVek’s patent-pending system will allow for simultaneous measurement of multiple markers in blood samples; a device that could be useful in determining drug doses for patients.

The CyVek system will consist of an instrument with disposable cartridges, which will measure proteins in blood and other bodily fluids, which would reflect the presence or severity of a disease.

CII awarded the grant through its Eli Whitney Fund as part of $3 million series C round of funding. CII invested $802,500 in the company in 2010.